We report a case of Henoch-Schonlein purpura that occurred in an adult patient with end-stage renal disease on continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD). The patient's skin lesions clearly decreased in number during HD, but not during CAPD. This finding has not been previously reported.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1346-8138.2006.00068.x | DOI Listing |
J Dermatol
December 2024
Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
Mod Rheumatol Case Rep
December 2024
Department of Rheumatology, Tokyo Bay Urayasu Ichikawa Medical Center, Chiba, Japan.
Diffuse alveolar hemorrhage (DAH) is a rare and severe complication of IgA vasculitis (IgAV). Although glucocorticoids and immunosuppressive agents are used for its treatment, there is no consensus on the optimal form of treatment. We herein report the case of a 53-year-old, female patient with IgAV.
View Article and Find Full Text PDFActa Paediatr
December 2024
Paediatric Nephrology Department, Great Ormond Street Hospital for Children, London, UK.
Beijing Da Xue Xue Bao Yi Xue Ban
December 2024
Department of Rheumatology and Immunology, Peking University Shougang Hospital, Beijing 100144, China.
Monoclonal gammopathy of undetermined significance combined with renal damage is named monoclonal gammopathy of renal significance. There are few reports about IgA vasculitis in patients with monoclonal gammopathy of undetermined significance. Here, we report a case of monoclonal gammopathy of renal significance, who had manifestations of IgA vasculitis, including purpura, gastrointestinal bleeding and joint pain.
View Article and Find Full Text PDFIndian J Nephrol
July 2024
Department of Nephrology, Madras Medical College, Chennai, Tamil Nadu, India.
Background: Several cases of glomerular diseases following Covid-19 vaccination, especially mRNA vaccines, have been reported. However, there is little data on glomerular diseases associated with the two vaccines widely available in India (Covaxin and Covishield) and their long-term outcomes.
Materials And Methods: This was a prospective observational study conducted between May 2021 and May 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!